![Zhui Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zhui Chen
Keine laufenden Positionen mehr
Vermögen: 21 Mio $ am 31.05.2026
Profil
Zhui Chen is the founder of Abbisko Cayman Ltd., founded in 2016, holding the title of Executive Director & Senior Vice President-Biology from 2018 to 2025.
Dr. Chen is the founder of Abbisko Therapeutics Co., Ltd., founded in 2016, holding the title of Chief Scientific Officer.
Current jobs include Chief Executive Officer at Otr Therapeutics Ltd. since 2025, Director at Abbisko Hong Kong Ltd. since 2018, Independent Non-Executive Director at Alebund Pharmaceuticals (Jiangsu) Ltd. since 2025, and Member of the American Association for Cancer Research since 2007.
Former job includes Associate Director at Johnson & Johnson China Ltd. from 2014 to 2016.
Education includes a doctorate from Duke University conferred in 2003 and an undergraduate degree from The University of Texas at Austin conferred in 1997.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ABBISKO CAYMAN LIMITED 2,38 % | 30.06.2025 | 17.207.394 ( 2,38 % ) | 21 Mio $ | 31.05.2026 |
Aktive Positionen von Zhui Chen
| Unternehmen | Position | Beginn |
|---|---|---|
Abbisko Hong Kong Ltd. | Direktor/Vorstandsmitglied | 01.03.2018 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Corporate Officer/Principal | 01.01.2007 |
Ehemalige bekannte Positionen von Zhui Chen
| Unternehmen | Position | Ende |
|---|---|---|
| ABBISKO CAYMAN LIMITED | Gründer | 03.03.2025 |
Johnson & Johnson China Ltd.
 Johnson & Johnson China Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 01.05.2016 |
Abbisko Therapeutics Co., Ltd.
 Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Gründer | - |
Ausbildung von Zhui Chen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
99
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
Johnson & Johnson China Ltd.
Johnson & Johnson China Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Health Technology |
Abbisko Cayman Ltd.
 Abbisko Cayman Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to the discovery and development of small molecule oncology therapies | Health Technology |
Abbisko Hong Kong Ltd. |
